Comparison of Continuous Positive Airway Pressure (CPAP) and Non-Invasive Positive Pressure Ventilation (NIPPV) in Preterm Newborns With Respiratory Distress Syndrome.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-44
SponsorVilnius University

About this trial

Primary objective: to evaluate safety and efficacy of two different non-invasive respiratory support modalities in preterm neonatal patients with respiratory distress syndrome.

Secondary objective is to compare different respiratory support mode performance in different gestational age groups.

Primary endpoint is treatment failure.

With this study, the following hypotheses will be tested:

Hypothesis 1: NIPPV has a lower failure rate compared to CPAP mode. Hypothesis 2: NIPPV complication rate is non-superior compared to CPAP.

Eligibility criteria

Qualifiers

gestational age (GA) between 22+0 and 34+6 weeks (estimated on the postmenstrual date and early gestation ultrasonographic findings).

Need of respiratory support (deemed by a clinician).

Disqualifiers

Major congenital anomalies

Cardiovascular instability

Consent refused or not provided

Trial design

Treatments tested in this trial

  • NIPPV
  • CPAP

Treatment groups

150 Participants
are divided into 2 treatment groups

Sponsors and collaborators